nodes	percent_of_prediction	percent_of_DWPC	metapath
Vidarabine—DPP4—Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1)—CDX2—Barrett's esophagus	0.0625	0.303	CbGpPWpGaD
Vidarabine—DPP4—Incretin synthesis, secretion, and inactivation—CDX2—Barrett's esophagus	0.0555	0.269	CbGpPWpGaD
Vidarabine—DPP4—exocrine gland—Barrett's esophagus	0.0541	0.329	CbGeAlD
Vidarabine—DPP4—epithelium—Barrett's esophagus	0.0235	0.143	CbGeAlD
Vidarabine—ADK—smooth muscle tissue—Barrett's esophagus	0.0234	0.142	CbGeAlD
Vidarabine—DPP4—smooth muscle tissue—Barrett's esophagus	0.0227	0.138	CbGeAlD
Vidarabine—ADA—digestive system—Barrett's esophagus	0.0226	0.138	CbGeAlD
Vidarabine—Scotoma—Omeprazole—Barrett's esophagus	0.022	0.0349	CcSEcCtD
Vidarabine—Scotoma—Esomeprazole—Barrett's esophagus	0.022	0.0349	CcSEcCtD
Vidarabine—DPP4—Peptide hormone metabolism—CDX2—Barrett's esophagus	0.0188	0.0914	CbGpPWpGaD
Vidarabine—DPP4—digestive system—Barrett's esophagus	0.0179	0.109	CbGeAlD
Vidarabine—Blood pressure increased—Omeprazole—Barrett's esophagus	0.0167	0.0265	CcSEcCtD
Vidarabine—Blood pressure increased—Esomeprazole—Barrett's esophagus	0.0167	0.0265	CcSEcCtD
Vidarabine—Injection site reaction—Esomeprazole—Barrett's esophagus	0.0166	0.0263	CcSEcCtD
Vidarabine—Injection site reaction—Omeprazole—Barrett's esophagus	0.0166	0.0263	CcSEcCtD
Vidarabine—Lightheadedness—Omeprazole—Barrett's esophagus	0.0149	0.0237	CcSEcCtD
Vidarabine—Lightheadedness—Esomeprazole—Barrett's esophagus	0.0149	0.0237	CcSEcCtD
Vidarabine—Bronchospasm—Esomeprazole—Barrett's esophagus	0.0103	0.0163	CcSEcCtD
Vidarabine—Bronchospasm—Omeprazole—Barrett's esophagus	0.0103	0.0163	CcSEcCtD
Vidarabine—ADA—Circadian rythm related genes—CRTC1—Barrett's esophagus	0.00968	0.047	CbGpPWpGaD
Vidarabine—Pollakiuria—Esomeprazole—Barrett's esophagus	0.00966	0.0153	CcSEcCtD
Vidarabine—Pollakiuria—Omeprazole—Barrett's esophagus	0.00966	0.0153	CcSEcCtD
Vidarabine—Bradycardia—Omeprazole—Barrett's esophagus	0.00852	0.0135	CcSEcCtD
Vidarabine—Bradycardia—Esomeprazole—Barrett's esophagus	0.00852	0.0135	CcSEcCtD
Vidarabine—Hypoaesthesia—Esomeprazole—Barrett's esophagus	0.00833	0.0132	CcSEcCtD
Vidarabine—Hypoaesthesia—Omeprazole—Barrett's esophagus	0.00833	0.0132	CcSEcCtD
Vidarabine—Tinnitus—Omeprazole—Barrett's esophagus	0.0078	0.0124	CcSEcCtD
Vidarabine—Tinnitus—Esomeprazole—Barrett's esophagus	0.0078	0.0124	CcSEcCtD
Vidarabine—Flushing—Omeprazole—Barrett's esophagus	0.00777	0.0123	CcSEcCtD
Vidarabine—Flushing—Esomeprazole—Barrett's esophagus	0.00777	0.0123	CcSEcCtD
Vidarabine—Mediastinal disorder—Omeprazole—Barrett's esophagus	0.00754	0.012	CcSEcCtD
Vidarabine—Mediastinal disorder—Esomeprazole—Barrett's esophagus	0.00754	0.012	CcSEcCtD
Vidarabine—Tension—Esomeprazole—Barrett's esophagus	0.00715	0.0114	CcSEcCtD
Vidarabine—Tension—Omeprazole—Barrett's esophagus	0.00715	0.0114	CcSEcCtD
Vidarabine—Dysgeusia—Esomeprazole—Barrett's esophagus	0.00714	0.0113	CcSEcCtD
Vidarabine—Dysgeusia—Omeprazole—Barrett's esophagus	0.00714	0.0113	CcSEcCtD
Vidarabine—Nervousness—Esomeprazole—Barrett's esophagus	0.00708	0.0112	CcSEcCtD
Vidarabine—Nervousness—Omeprazole—Barrett's esophagus	0.00708	0.0112	CcSEcCtD
Vidarabine—Back pain—Omeprazole—Barrett's esophagus	0.00705	0.0112	CcSEcCtD
Vidarabine—Back pain—Esomeprazole—Barrett's esophagus	0.00705	0.0112	CcSEcCtD
Vidarabine—Vision blurred—Omeprazole—Barrett's esophagus	0.00687	0.0109	CcSEcCtD
Vidarabine—Vision blurred—Esomeprazole—Barrett's esophagus	0.00687	0.0109	CcSEcCtD
Vidarabine—Tremor—Esomeprazole—Barrett's esophagus	0.00683	0.0108	CcSEcCtD
Vidarabine—Tremor—Omeprazole—Barrett's esophagus	0.00683	0.0108	CcSEcCtD
Vidarabine—Agitation—Omeprazole—Barrett's esophagus	0.0067	0.0106	CcSEcCtD
Vidarabine—Agitation—Esomeprazole—Barrett's esophagus	0.0067	0.0106	CcSEcCtD
Vidarabine—Angioedema—Esomeprazole—Barrett's esophagus	0.00666	0.0106	CcSEcCtD
Vidarabine—Angioedema—Omeprazole—Barrett's esophagus	0.00666	0.0106	CcSEcCtD
Vidarabine—Palpitations—Esomeprazole—Barrett's esophagus	0.00644	0.0102	CcSEcCtD
Vidarabine—Palpitations—Omeprazole—Barrett's esophagus	0.00644	0.0102	CcSEcCtD
Vidarabine—Cough—Omeprazole—Barrett's esophagus	0.00636	0.0101	CcSEcCtD
Vidarabine—Cough—Esomeprazole—Barrett's esophagus	0.00636	0.0101	CcSEcCtD
Vidarabine—Hypertension—Omeprazole—Barrett's esophagus	0.00629	0.00999	CcSEcCtD
Vidarabine—Hypertension—Esomeprazole—Barrett's esophagus	0.00629	0.00999	CcSEcCtD
Vidarabine—Chest pain—Esomeprazole—Barrett's esophagus	0.0062	0.00985	CcSEcCtD
Vidarabine—Chest pain—Omeprazole—Barrett's esophagus	0.0062	0.00985	CcSEcCtD
Vidarabine—Anxiety—Esomeprazole—Barrett's esophagus	0.00618	0.00982	CcSEcCtD
Vidarabine—Anxiety—Omeprazole—Barrett's esophagus	0.00618	0.00982	CcSEcCtD
Vidarabine—Discomfort—Omeprazole—Barrett's esophagus	0.00613	0.00974	CcSEcCtD
Vidarabine—Discomfort—Esomeprazole—Barrett's esophagus	0.00613	0.00974	CcSEcCtD
Vidarabine—Dry mouth—Esomeprazole—Barrett's esophagus	0.00607	0.00964	CcSEcCtD
Vidarabine—Dry mouth—Omeprazole—Barrett's esophagus	0.00607	0.00964	CcSEcCtD
Vidarabine—Anaphylactic shock—Omeprazole—Barrett's esophagus	0.00595	0.00945	CcSEcCtD
Vidarabine—Anaphylactic shock—Esomeprazole—Barrett's esophagus	0.00595	0.00945	CcSEcCtD
Vidarabine—ADA—Validated transcriptional targets of deltaNp63 isoforms—CDKN2A—Barrett's esophagus	0.00594	0.0288	CbGpPWpGaD
Vidarabine—Shock—Esomeprazole—Barrett's esophagus	0.00585	0.00929	CcSEcCtD
Vidarabine—Shock—Omeprazole—Barrett's esophagus	0.00585	0.00929	CcSEcCtD
Vidarabine—Tachycardia—Esomeprazole—Barrett's esophagus	0.0058	0.00922	CcSEcCtD
Vidarabine—Tachycardia—Omeprazole—Barrett's esophagus	0.0058	0.00922	CcSEcCtD
Vidarabine—Hyperhidrosis—Esomeprazole—Barrett's esophagus	0.00575	0.00913	CcSEcCtD
Vidarabine—Hyperhidrosis—Omeprazole—Barrett's esophagus	0.00575	0.00913	CcSEcCtD
Vidarabine—ADORA2A—Circadian rythm related genes—CRTC1—Barrett's esophagus	0.00556	0.027	CbGpPWpGaD
Vidarabine—Musculoskeletal discomfort—Esomeprazole—Barrett's esophagus	0.00542	0.00861	CcSEcCtD
Vidarabine—Musculoskeletal discomfort—Omeprazole—Barrett's esophagus	0.00542	0.00861	CcSEcCtD
Vidarabine—Paraesthesia—Omeprazole—Barrett's esophagus	0.00534	0.00848	CcSEcCtD
Vidarabine—Paraesthesia—Esomeprazole—Barrett's esophagus	0.00534	0.00848	CcSEcCtD
Vidarabine—ADA—Validated transcriptional targets of TAp63 isoforms—CDKN2A—Barrett's esophagus	0.00532	0.0258	CbGpPWpGaD
Vidarabine—Dyspnoea—Esomeprazole—Barrett's esophagus	0.0053	0.00842	CcSEcCtD
Vidarabine—Dyspnoea—Omeprazole—Barrett's esophagus	0.0053	0.00842	CcSEcCtD
Vidarabine—Somnolence—Omeprazole—Barrett's esophagus	0.00529	0.0084	CcSEcCtD
Vidarabine—Somnolence—Esomeprazole—Barrett's esophagus	0.00529	0.0084	CcSEcCtD
Vidarabine—Pain—Omeprazole—Barrett's esophagus	0.00509	0.00808	CcSEcCtD
Vidarabine—Pain—Esomeprazole—Barrett's esophagus	0.00509	0.00808	CcSEcCtD
Vidarabine—Urticaria—Esomeprazole—Barrett's esophagus	0.00472	0.0075	CcSEcCtD
Vidarabine—Urticaria—Omeprazole—Barrett's esophagus	0.00472	0.0075	CcSEcCtD
Vidarabine—Hypersensitivity—Omeprazole—Barrett's esophagus	0.00438	0.00696	CcSEcCtD
Vidarabine—Hypersensitivity—Esomeprazole—Barrett's esophagus	0.00438	0.00696	CcSEcCtD
Vidarabine—Asthenia—Esomeprazole—Barrett's esophagus	0.00427	0.00678	CcSEcCtD
Vidarabine—Asthenia—Omeprazole—Barrett's esophagus	0.00427	0.00678	CcSEcCtD
Vidarabine—Dizziness—Esomeprazole—Barrett's esophagus	0.00393	0.00625	CcSEcCtD
Vidarabine—Dizziness—Omeprazole—Barrett's esophagus	0.00393	0.00625	CcSEcCtD
Vidarabine—Vomiting—Esomeprazole—Barrett's esophagus	0.00378	0.00601	CcSEcCtD
Vidarabine—Vomiting—Omeprazole—Barrett's esophagus	0.00378	0.00601	CcSEcCtD
Vidarabine—ADA—p73 transcription factor network—RELA—Barrett's esophagus	0.00377	0.0183	CbGpPWpGaD
Vidarabine—Rash—Omeprazole—Barrett's esophagus	0.00375	0.00596	CcSEcCtD
Vidarabine—Rash—Esomeprazole—Barrett's esophagus	0.00375	0.00596	CcSEcCtD
Vidarabine—Dermatitis—Esomeprazole—Barrett's esophagus	0.00375	0.00595	CcSEcCtD
Vidarabine—Dermatitis—Omeprazole—Barrett's esophagus	0.00375	0.00595	CcSEcCtD
Vidarabine—ADA—C-MYB transcription factor network—CDKN2A—Barrett's esophagus	0.00373	0.0181	CbGpPWpGaD
Vidarabine—Headache—Omeprazole—Barrett's esophagus	0.00373	0.00592	CcSEcCtD
Vidarabine—Headache—Esomeprazole—Barrett's esophagus	0.00373	0.00592	CcSEcCtD
Vidarabine—DPP4—Metabolism of proteins—CDX2—Barrett's esophagus	0.00356	0.0173	CbGpPWpGaD
Vidarabine—Nausea—Omeprazole—Barrett's esophagus	0.00353	0.00561	CcSEcCtD
Vidarabine—Nausea—Esomeprazole—Barrett's esophagus	0.00353	0.00561	CcSEcCtD
Vidarabine—ADA—C-MYB transcription factor network—PTGS2—Barrett's esophagus	0.00349	0.0169	CbGpPWpGaD
Vidarabine—ADK—Metabolism—PTGES—Barrett's esophagus	0.00252	0.0122	CbGpPWpGaD
Vidarabine—ADA—Circadian rythm related genes—PPARG—Barrett's esophagus	0.00221	0.0107	CbGpPWpGaD
Vidarabine—ADK—Metabolism—CYP26A1—Barrett's esophagus	0.00191	0.00928	CbGpPWpGaD
Vidarabine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—SST—Barrett's esophagus	0.00174	0.00845	CbGpPWpGaD
Vidarabine—ADA—Metabolism—PTGES—Barrett's esophagus	0.00171	0.00832	CbGpPWpGaD
Vidarabine—ADK—Metabolism—SLC9A1—Barrett's esophagus	0.00138	0.00669	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR ligand binding—SST—Barrett's esophagus	0.00133	0.00644	CbGpPWpGaD
Vidarabine—ADA—Metabolism—CYP26A1—Barrett's esophagus	0.0013	0.0063	CbGpPWpGaD
Vidarabine—ADORA2A—Circadian rythm related genes—PPARG—Barrett's esophagus	0.00127	0.00615	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—GAST—Barrett's esophagus	0.00109	0.00531	CbGpPWpGaD
Vidarabine—ADA—Circadian rythm related genes—TP53—Barrett's esophagus	0.00103	0.00501	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—GAST—Barrett's esophagus	0.000993	0.00482	CbGpPWpGaD
Vidarabine—ADA—Metabolism—SLC9A1—Barrett's esophagus	0.000937	0.00454	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by NGF—RELA—Barrett's esophagus	0.000774	0.00376	CbGpPWpGaD
Vidarabine—DPP4—Metabolism of proteins—CXCL8—Barrett's esophagus	0.000759	0.00368	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—SST—Barrett's esophagus	0.00075	0.00364	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—SST—Barrett's esophagus	0.000681	0.0033	CbGpPWpGaD
Vidarabine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—CXCL8—Barrett's esophagus	0.000679	0.00329	CbGpPWpGaD
Vidarabine—ADK—Metabolism—PPARG—Barrett's esophagus	0.000629	0.00305	CbGpPWpGaD
Vidarabine—ADORA2A—Circadian rythm related genes—TP53—Barrett's esophagus	0.000594	0.00288	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—GAST—Barrett's esophagus	0.000587	0.00285	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR ligand binding—CXCL8—Barrett's esophagus	0.000517	0.00251	CbGpPWpGaD
Vidarabine—ADK—Metabolism—PTGS2—Barrett's esophagus	0.000495	0.0024	CbGpPWpGaD
Vidarabine—ADA—Metabolism—PPARG—Barrett's esophagus	0.000428	0.00207	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—SST—Barrett's esophagus	0.000402	0.00195	CbGpPWpGaD
Vidarabine—ADA—Metabolism—PTGS2—Barrett's esophagus	0.000336	0.00163	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—CXCL8—Barrett's esophagus	0.000292	0.00142	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—CXCL8—Barrett's esophagus	0.000265	0.00129	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—APC—Barrett's esophagus	0.000213	0.00103	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—RELA—Barrett's esophagus	0.000166	0.000807	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—CXCL8—Barrett's esophagus	0.000157	0.00076	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—TP53—Barrett's esophagus	9.62e-05	0.000466	CbGpPWpGaD
